CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE1467.25-51.35 (-3.38 %)
PREV CLOSE () 1518.60
OPEN PRICE () 1534.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29581
TODAY'S LOW / HIGH ()1444.05 1534.70
52 WK LOW / HIGH ()402.85 1580
NSE1465.65-53.55 (-3.52 %)
PREV CLOSE() 1519.20
OPEN PRICE () 1530.05
BID PRICE (QTY) 1465.65 (269)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 525423
TODAY'S LOW / HIGH() 1444.75 1534.80
52 WK LOW / HIGH ()402.65 1582.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1999

Management Info :

Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director

Registered Office :

Address : D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone : 0240-6632222 / 6694444

Website : www.wockhardt.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
03Jan Wockhardt secures approval from CDSCO
Wockhardt has received an approval from the Indian drug regulator, Centr..
03Jan Wockhardt zooms on securing approval f
Wockhardt is currently trading at Rs. 1538.00, up by 92.25 points or 6.3..
16Dec Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..
11Nov QIP
532300 | Announcement under Regulation 30 (LODR)-Allotment Company Up..
21Oct Wockhardt informs about investor prese
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit-360-4220
Gross Profit -360 -4220
Operating Profit 60050
Net Sales 370011540
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29939.60 (1.58%)
M.Cap ( in Cr)
63619.56
Astrazeneca Pharma I (BSE)
 7251.75 (1.94%)
M.Cap ( in Cr)
18129.38
Ajanta Pharma (BSE)
 2948.80 (2.70%)
M.Cap ( in Cr)
36834.08
Concord Biotech (BSE)
 2158.60 (3.38%)
M.Cap ( in Cr)
22582.45
Alkem Laboratories (BSE)
 5524.45 (0.44%)
M.Cap ( in Cr)
66053.09
Shareholding Pattern
PROMOTERS 51.99%
NON-INSTITUTION 36.21%
MUTUAL FUNDS/UTI 2.95%
GOVERNMENT 0.02%
FI/BANKS/INSURANCE 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77964.99-1258.12 (-1.59%)
NIFTY23616.05-388.70 (-1.62%)
Dow Jones 42732.13339.86 (0.80%)
Nasdaq 19621.68340.89 (1.77%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI